Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 1229
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure

Pradhan Akshyaya, Vohra Shweta, Vishwakarma Pravesh, Sethi Rishi

Year : 2019| Volume: 8| Issue : 6 | Page no: 1855-1862

   This article has been cited by
1 Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial
Ahmad Haidar,Jean-Francois Yale,Leif Erik Lovblom,Nancy Cardinez,Andrej Orszag,C. Marcelo Falappa,Nikita Gouchie-Provencher,Michael A. Tsoukas,Anas El Fathi,Jennifer Rene,Devrim Eldelekli,Sebastien O. Lanctôt,Daniel Scarr,Bruce A. Perkins
Diabetes, Obesity and Metabolism. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats
Ghulam Md Ashraf,Badrah S. Alghamdi,Fahad S. Alshehri,Mohammad Zubair Alam,Haythum O. Tayeb,Frank I. Tarazi
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
3 A Clinical Study on the Association of Sodium-Glucose Cotransporter 2 Inhibitors and Acute Kidney Injury Among Diabetic Chinese Population
Lianglan Shen,Hongli Yang,Xingxing Fang,Huaxing Huang,Wubin Yao,Dongmei Chen,Yan Shen
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021; Volume 14: 1621
[Pubmed]  [Google Scholar] [DOI]
4 Sodium-Glucose Co-transporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus Without Established Cardiovascular Disease: Do They Have a Role in Primary Prevention?
Dr Shailaja Kale,Dr Abd A Tahrani
Metabolism Open. 2021; : 100082
[Pubmed]  [Google Scholar] [DOI]
5 Drug-drug interactions when treating HIV-related metabolic disorders
Maria del Mar Gutierrez,Mª Gracia Mateo,Noemí Corbacho,Francesc Vidal,Pere Domingo
Expert Opinion on Drug Metabolism & Toxicology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article